Obama Submits Science-Boosting Budget

But some critics say the President relies too heavily on mandatory funding to support the biomedical research enterprise.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, REVISORWEBPresident Barack Obama has finalized his FY2017 federal budget proposal and, at first glance, science seems to fare alright in the plan. But the President relies on mandatory funds, which historically haven’t had an easy path through Congress, to boost budgets at the National Institutes of Health (NIH) and other federal science agencies. Under the proposed budget, the NIH would get an $825 million boost, raising its annual budget to $33.1 billion; the National Science Foundation would get a $900 million increase; and the Department of Energy’s Office of Science would get a $325 million boost. Several big science initiatives also stand to get more funding: a $45 million boost to the BRAIN Initiative, $300 million for the White House’s precision medicine program, and $755 million to launch the “cancer moonshot” Obama announced in his last State of the Union address.

But much of these funding increases depend on Congress passing mandatory funding allocations, which has been a sticky proposition in years past. If that mandatory funding doesn’t make it through the legislative sausage grinder, the NIH is set to have its budget cut by $1 billion in 2017, according to an analysis by the American Association for the Advancement of Science that was cited by The Chronicle of Higher Education.

“While we appreciate that President Obama’s overall goal is to increase funding for biomedical research, we are disappointed his proposed budget would actually decrease the baseline funding level for the National Institutes of Health (NIH) in FY2017,” advocacy group United for Medical Research said in a statement. “It is essential that funding for the NIH ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies